Asst Bergamo Ovest Joins (H) Open Day for Migraine Awareness
Asst Bergamo Ovest will participate in the fourth edition of the (H) Open Day Emicrania on June 17, an initiative promoted by Fondazione Onda ETS to raise public awareness about migraine disease. Migraine is a chronic, disabling neurological condition that affects approximately 14% of the adult population globally. In Italy, the condition impacts over 6 million people, with women experiencing the disease at a rate three times higher than men, according to data cited by the organization.
Did You Know? Migraine is recognized by the World Health Organization as one of the primary causes of disability worldwide, yet it remains frequently under-diagnosed and under-treated.
Why Migraine Awareness Matters
The significance of the (H) Open Day lies in addressing the stigma surrounding migraine, which is often dismissed as a minor headache. According to the initiative’s organizers, this perception can lead to delays in diagnosis and treatment, potentially allowing the condition to become chronic. Because the disease involves recurring headache attacks often accompanied by nausea, vomiting, and sensitivity to light and sound, it significantly impairs personal, family, and professional life. Early intervention and specialized care are recommended to mitigate these long-term impacts.
Focus on Hormonal Health
For the 2026 edition, Asst Bergamo Ovest is focusing specifically on the relationship between migraines and the female hormonal state. Dr. Giovanna Bosco, representing the Neurology department and the Migraine Clinic, has developed specialized information materials to be distributed during the event. Beginning the week of June 17, these resources will be available on the company’s social media channels and via digital screens located in the Community Houses and Consultories. A new brochure detailing the pathology, potential triggers, and available treatment pathways will also be provided to the public.
Expert Insight: The focus on hormonal influence highlights a critical gap in public understanding. By emphasizing the biological factors that contribute to the higher prevalence of migraine in women, health providers may improve the rate of early diagnosis and reduce the social stigma that prevents many patients from seeking timely, specialized care.
What May Happen Next
Following the awareness campaign, it is likely that the local health authority will see an increase in inquiries regarding clinical pathways for migraine management. If the dissemination of information successfully reaches the target demographic, patients may be more inclined to consult with specialists at the Migraine Clinic. Future efforts could focus on integrating these hormonal-focused educational materials into routine check-ups at Consultories to ensure ongoing support for patients managing chronic symptoms.
Frequently Asked Questions
What is the primary goal of the (H) Open Day Emicrania?
The objective is to raise awareness among the population regarding migraine, a widespread but often underestimated chronic and disabling neurological disease.
Why are women more affected by migraines than men?
According to the provided information, women are affected at a frequency approximately three times higher than men, due in part to the influence of female hormones.
Where can citizens find information during the June 17 initiative?
Information will be available on social media channels, on screens within Community Houses and Consultories, and through a new brochure created by Dr. Giovanna Bosco.
How does the stigma surrounding migraine impact the lives of those suffering from the condition?